Our Website Uses Cookies 

We and the third parties that provide content, functionality, or business services on our website may use cookies to collect information about your browsing activities in order to provide you with more relevant content and promotional materials, on and off the website, and help us understand your interests and improve the website.

For more information, please contact us or consult our Privacy Notice.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

Jennifer Robbins concentrates her practice on patent prosecution and post-grant Patent Office proceedings, including Patent Trial and Appeal Board (PTAB) matters. She has successfully represented patent owners in numerous PTAB matters. She also advises life sciences clients on obtaining and managing patent protection.

  • Represented Biogen in inter partes review (IPR) proceedings brought by a competitor to challenge three patents covering Tysabri®; the PTAB declined to institute trial on all three patents.
  • Represented patent owner in a series of IPR proceedings challenging the patent claiming the anti-epileptic drug Vimpat®; the PTAB rejected all challenges.
  • Represented patent owner in an IPR proceeding challenging a patent concerning Avastin®; the PTAB declined to institute trial and rejected the challenge.
  • Successfully defended Alza Corp. in an inventorship dispute concerning the drug product Concerta®.
  • Represented Shire LLC in a series of Hatch-Waxman litigations concerning its drug product Adderall XR®.   

Pro Bono

  • Representing post–9/11 detainees in pursuing claims of unlawful detention and subjection to abusive conditions.

Previous Experience

  • Drafted and prosecuted patent applications as a patent agent (2005-2007).
  • Interned for the Honorable John Koeltl in the United States District Court for the Southern District of New York (Fall 2008).